期刊文献+

毕赤酵母表达肽抗生素hPAB-β的纯化 被引量:4

Purification of peptide antibiotic hPAB-β from recombinant Pichia pastoris
下载PDF
导出
摘要 目的在成功构建肽抗生素hPAB-β重组毕赤酵母的基础上,深入探讨酵母表达hPAB-β的规模化纯化方法。方法采用高密度发酵法在3.7L发酵罐中对pPIC9K-hPAB-β/GS115优5重组菌株进行发酵,收集发酵液,依次采用W-UF-Ⅱ过滤系统超滤、反相层析、阳离子交换、分子筛层析等纯化技术对目标表达产物逐级进行纯化,目的蛋白用15%的Tricine-SDS-PAGE电泳进行跟踪分析。最终纯化产物的生物学活性用平板琼脂扩散法进行测定。结果在培养至工程菌菌体湿重约200~250g/L时,以甲醇诱导培养基诱导目的蛋白表达,48h后菌体湿重达280g/L,目标产物表达量约75mg/L。发酵液经Mr10000膜超滤,达到去除大部分酵母色素和浓缩样品的目的(体积浓缩约2/3)。再经反相层析、离子交换、分子筛层析纯化,最终目的产物的纯度达98%以上,得率达32.5%。且纯化的目的蛋白具有良好的杀灭金黄色葡萄球菌和铜绿假单胞菌的活性。结论酵母表达肽抗生素hPAB-β经膜超滤、反相层析、离子交换和分子筛层析四步纯化,实现了去除非目的蛋白、酵母色素及脱盐的目的,为规模化制备hPAB-β创造了前提。 Objective To probe the purification of human peptide antibiotics (hPAB-β) derived from high-density fermentation of Pichia pastoris. Methods The recombinant Pichia pastoris strain pPIC9K-hPAB-β/GS115 you5 was cultured in a fermentor (3.7 L) and induced with methanol to express hPAB-β. The fermentative supematant was collected and subjected to purification with membrane ultraffiltration, reverse phase chromatography, cation exchange, and molecular sieve chromatography by turns. The existence of hPAB-β during the processes was determined by Tricine-SDS-PAGE analysis. The biological activity of the purified hPAB-β was identified by agar-well diffusion assay. Resuits The expression of recombinant hPAB-β was induced by methanol when the wet weight of Pichia pastoris achieved 200 - 250 g/L. The wet weight of Pichia pastoris reached around 280 g/L after 48 h of continuous induction and the yield of hPAB-β was about 75 mg/L. The purification of hPAB-β from fermentative supematants with the Mr 10 000 membrane ultrafiltration was almost removed the saccharemycetic pigments and the volume containing the target protein was also concentrated around 2/3. The final purity of hPAB-β was above 98% after purification by reverse phase chromatography, cation exchange, and molecular sieve chromatography. The purified recombinant peptide hPAB-β retained its bacteriocidal activity against Staphylococcus aureus and Pseduomonas aeruginosa. Conclusion The purification strategy of peptide antibiotics hPAB-β from the fermentative supematants of recombinant Pichia pastoris was succesfully constructed, which will facilitate the large-scale preparation of hPAB-β from recombinant Pichia pastoris.
出处 《免疫学杂志》 CAS CSCD 北大核心 2008年第3期332-336,共5页 Immunological Journal
基金 全军"十一五"攻关课题(06G075) 重庆市攻关课题(CSTC.2005AB5021) 国家自然科学基金(30772061)资助项目
关键词 毕赤酵母 肽抗生素 hPAB-β 发酵 纯化 Pichin pastoris Peptide antibiotics hPAB-β High-density fermentation Purification
  • 相关文献

参考文献15

  • 1饶贤才,胡福泉.肽抗生素,控制感染的新希望[J].生命的化学,2001,21(5):357-359. 被引量:22
  • 2胡福泉.肽抗生素研究进展及其应用前景[J].微生物学杂志,2003,23(2):59-60. 被引量:2
  • 3Rao X, Hu J, Li S, et al. Design and expression of peptide antibiotic hPAB-β as tandem multimers in Escherichia coli [J]. Peptides, 2005, 26 (5): 721- 729.
  • 4侯瑞,饶贤才,陈志瑾,杨杰,胡晓梅,丛延广,谭银玲,胡福泉.肽抗生素hPAB-β在毕赤酵母中的表达与活性鉴定[J].免疫学杂志,2007,23(3):277-282. 被引量:8
  • 5Gallo RL. Sounding the Mann: multiple functions of host defense peptides [ J ]. J Invest Dermatol, 2008, 128 ( 1 ) : 5-6.
  • 6Schauber J, Ruzicka T, Rupec RA. Cathelicidin LL-37: A central factor in the pathogenesis of inflammatory dermatoses [J]. Hautarzt, 2008, 59 (1): 72-74
  • 7陆建荣,王惠民,凌勇武,黄松平,常秋月.人源多肽抗生素LL-37真核表达载体的构建[J].临床检验杂志,2007,25(3):185-188. 被引量:2
  • 8F.M.奥斯伯,R.E.金斯顿,V.G.塞德曼,等.精编分子生物学实验指南[M].北京:科学出版社,2006:416-450.
  • 9Gutierrez J, Criado R, Martin M, et al. Production of enterocin P, an antilisl~dal pediocin-like bacteriocin from enterococcus faecium P13, in Pichia pastofis [ J]. Antimicrob Agents Chemother, 2005, 49 (7) : 3 004 - 3 008.
  • 10Fellermann K, Wehkamp J, Stange EF. Antimicrobial peptides in the skin [ J ]. N Engl J Med, 2003, 348 (4): 361 - 363.

二级参考文献41

  • 1张杰,吴希,岳园园,陈玉清,张双全.抗菌肽CM4基因克隆及其在毕赤酵母中的表达鉴定[J].微生物学报,2005,45(5):720-723. 被引量:11
  • 2屠益增,屈贤铭,许廷森.家蚕抗菌肽CM_2Ph_1的分离、纯化、结构及其性质的研究[J].中国科学(B辑),1989(5):473-480. 被引量:7
  • 3Li P,Science,2001年,291卷,5509期,1783页
  • 4Boman H G.Peptide antibiotics and their role in innate immunity.Annu Rev Immunol,1995,13:61-92.
  • 5Boman H G.Antibacterial peptides:basic facts and emerging concepts.J Intern Med,2003,254(3):197-215.
  • 6Hancock R E,Patrzykat A.Clinical development of cationic antimicrobial peptides:from natural to novel antibiotics.Curr Drug Targets Infect Disord,2002,2(1):79-83.
  • 7Diamond G.Natures antibiotics:the potential of antimicrobial peptides as new drugs.Biologist(London),2001,48(5):209-212.
  • 8Bals R.Antimicrobial peptides and peptide amtibiotics.Med Klin(Munich),2000,95(9):496-502.
  • 9Nozomi K,Tomoyas A,Hiroshi S,et al.Expression and purification of a small cytokine growth-blocking peptide from armyworm Pseudaletia separate by an optimized fermentation method using the methylotrophic yeast Pichia pastoris.Protein Expression and Purification,2002,25:416-425.
  • 10Dan H,Ake E,Hans B.Insect Immunity:Isolation and structure of cecropin D and fourminor antibacterial components from cecropia pupae.Eur J Biochem,1982,127:207-217.

共引文献38

同被引文献66

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部